A hepatitis C vaccine for newborns is a preventive shot designed to protect infants from contracting hepatitis C virus (HCV) infections. Unlike hepatitis B vaccines, which have been available for decades, no FDA-approved hepatitis C vaccine exists yet.
Since no hepatitis C vaccine exists, doctors focus on reducing transmission risks. Pregnant women receive HCV testing, and those with HCV may take antiviral treatments to lower viral loads before delivery. Cesarean sections can reduce transmission risks, though not all infected mothers require them.
The hepatitis C virus mutates rapidly, making vaccine development difficult. Researchers explore various approaches, including prophylactic vaccines to prevent infection and therapeutic vaccines to help the immune system clear existing infections. Clinical trials are ongoing, but widespread availability remains years away.
Researchers remain optimistic about developing a hepatitis C vaccine. Ongoing clinical trials test different vaccine candidates, with some showing promising results. Until then, prevention focuses on reducing transmission risks and treating infected individuals effectively.